Steering committee

A consortium of doctors, researchers, biologists, anatomopathologists, scientists, manufacturers, drug specialists and artificial intelligence specialists has been set up to develop new diagnostic, prognostic and therapeutic tools for cutaneous T lymphomas, in order to improve the management of patients suffering from these diseases.

The consortium comprises academic partners, including Université Paris Cité, the coordinating institution, and industrial partners and associations.

© Part of the RHU SPRINT team at the Pre-Kick-Off Meeting. Credits : RHU SPRINT.

Consortium members

Prof. Martine BAGOT, Dermatologist

Cutaneous lymphoma KOL. Lacutamab (IPH4102), jointly developed, is currently undergoing an international Phase 2 trial.

Prof. Maxime BATTISTELLA, Pathologist

Expert member of EORTC, Cutaneous Lymphoma Group & International Society of Cutaneous Lymphomas

Prof. Marie BEYLOT-BARRY, Head of Dermatology, Bordeaux University Hospital

Co-Director, INSERM BRIC Team 5, General Secretary, GFELC

Board of Directors, International Society of Cutaneous Lymphomas

Dr. Lucie BIARD, Biostatistics

Specialist in early-phase clinical trial design INCa-certified data processing center

Prof. Stéphane DALLE, Head of Dermatology Department, Hospices Civils Lyon

Co-leader of the Qualitop Cancer Research Center research team, coordinating team for the European H2020 project

Prof. Adèle de MASSON, Project Coordinator

Dermatologist, Coordinator of the French National Cutaneous Lymphoma Network (INCa)

Prof. Isabelle DURAND-ZALESKI, Medical Economics

Head of the AP-HP clinical research unit on health economics and health services

Prof. Nikos PARAGIOS, AI-precision medicine

Professor Emeritus of Mathematics, CEO of TheraPanacea, world-renowned expert in artificial intelligence

Dr. Stephan SCHANN, Immuno-oncology, drug development

Chief Scientific Officer of Domain Therapeutics, an R&D expert in next-generation immunotherapies and leader of Domain’s proprietary programmes targeting GPCRs.

Read more

RHU SPRINT kick-off meeting

RHU SPRINT kick-off meeting

The kick-off meeting for the RHU SPRINT hospital-university research project, Synergy to accelerate therapeutic innovation in cutaneous T lymphoma, took place on Monday, May 27, 2024. RHU SPRINT Kick-Off The meeting was held at the Faculté de Villemin, in the presence...